vs
艾伯维（ABBV）与Smurfit Westrock（SW）财务数据对比。点击上方公司名可切换其他公司
艾伯维的季度营收约是Smurfit Westrock的1.9倍（$15.0B vs $7.7B），艾伯维净利率更高（4.6% vs 0.8%，领先3.8%），艾伯维同比增速更快（9.9% vs 0.7%），过去两年Smurfit Westrock的营收复合增速更高（61.2% vs 1.8%）
艾伯维是一家总部位于美国伊利诺伊州北芝加哥的制药企业，专注于研发、生产覆盖多种疾病领域的治疗药物，致力于为全球各地患者提供安全有效的临床解决方案，在全球医药行业拥有较高的知名度与影响力。
Smurfit Westrock plc是总部位于爱尔兰都柏林的企业，核心业务为生产瓦楞包装及各类纸制包装产品，公司股票同时在纽约证券交易所和伦敦证券交易所挂牌上市。
ABBV vs SW — 直观对比
营收规模更大
ABBV
是对方的1.9倍
$7.7B
营收增速更快
ABBV
高出9.2%
0.7%
净利率更高
ABBV
高出3.8%
0.8%
两年增速更快
SW
近两年复合增速
1.8%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $15.0B | $7.7B |
| 净利润 | $697.0M | $63.0M |
| 毛利率 | — | 16.4% |
| 营业利润率 | 26.6% | 3.3% |
| 净利率 | 4.6% | 0.8% |
| 营收同比 | 9.9% | 0.7% |
| 净利润同比 | -46.0% | 0.0% |
| 每股收益（稀释后） | $0.39 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABBVSW
| Q1 26 | $15.0B | $7.7B | ||
| Q4 25 | $16.6B | $7.6B | ||
| Q3 25 | $15.8B | $8.0B | ||
| Q2 25 | $15.4B | $7.9B | ||
| Q1 25 | $13.3B | $7.7B | ||
| Q4 24 | $15.1B | $7.5B | ||
| Q3 24 | $14.5B | $7.7B | ||
| Q2 24 | $14.5B | $3.0B |
净利润ABBVSW
| Q1 26 | $697.0M | $63.0M | ||
| Q4 25 | $1.8B | $97.0M | ||
| Q3 25 | $186.0M | $246.0M | ||
| Q2 25 | $938.0M | $-28.0M | ||
| Q1 25 | $1.3B | $384.0M | ||
| Q4 24 | $-22.0M | $146.0M | ||
| Q3 24 | $1.6B | $-150.0M | ||
| Q2 24 | $1.4B | $132.0M |
毛利率ABBVSW
| Q1 26 | — | 16.4% | ||
| Q4 25 | 72.6% | 18.2% | ||
| Q3 25 | 66.4% | 19.6% | ||
| Q2 25 | 71.8% | 19.1% | ||
| Q1 25 | 70.0% | 20.6% | ||
| Q4 24 | 70.9% | 19.1% | ||
| Q3 24 | 70.9% | 17.6% | ||
| Q2 24 | 70.9% | 23.3% |
营业利润率ABBVSW
| Q1 26 | 26.6% | 3.3% | ||
| Q4 25 | 27.3% | 5.1% | ||
| Q3 25 | 12.1% | 6.6% | ||
| Q2 25 | 31.7% | 3.2% | ||
| Q1 25 | 28.0% | 7.2% | ||
| Q4 24 | -9.9% | 5.3% | ||
| Q3 24 | 26.5% | 0.7% | ||
| Q2 24 | 27.6% | 8.2% |
净利率ABBVSW
| Q1 26 | 4.6% | 0.8% | ||
| Q4 25 | 10.9% | 1.3% | ||
| Q3 25 | 1.2% | 3.1% | ||
| Q2 25 | 6.1% | -0.4% | ||
| Q1 25 | 9.6% | 5.0% | ||
| Q4 24 | -0.1% | 1.9% | ||
| Q3 24 | 10.8% | -2.0% | ||
| Q2 24 | 9.5% | 4.4% |
每股收益（稀释后）ABBVSW
| Q1 26 | $0.39 | $0.12 | ||
| Q4 25 | $1.02 | $0.18 | ||
| Q3 25 | $0.10 | $0.47 | ||
| Q2 25 | $0.52 | $-0.05 | ||
| Q1 25 | $0.72 | $0.73 | ||
| Q4 24 | $-0.03 | $-0.12 | ||
| Q3 24 | $0.88 | $-0.30 | ||
| Q2 24 | $0.77 | $0.51 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | — |
| 总债务越低越好 | — | $980.0M |
| 股东权益账面价值 | — | $18.1B |
| 总资产 | — | $45.2B |
| 负债/权益比越低杠杆越低 | — | 0.05× |
8季度趋势，按日历期对齐
现金及短期投资ABBVSW
| Q1 26 | — | — | ||
| Q4 25 | $5.3B | $892.0M | ||
| Q3 25 | $5.7B | $851.0M | ||
| Q2 25 | $6.5B | $778.0M | ||
| Q1 25 | $5.2B | $797.0M | ||
| Q4 24 | $5.6B | $855.0M | ||
| Q3 24 | $7.3B | — | ||
| Q2 24 | $13.2B | $26.8K |
总债务ABBVSW
| Q1 26 | — | $980.0M | ||
| Q4 25 | $58.9B | $13.4B | ||
| Q3 25 | $63.0B | $13.3B | ||
| Q2 25 | $63.0B | $13.3B | ||
| Q1 25 | $64.5B | $12.9B | ||
| Q4 24 | $60.3B | $12.5B | ||
| Q3 24 | $58.5B | $13.2B | ||
| Q2 24 | $58.0B | — |
股东权益ABBVSW
| Q1 26 | — | $18.1B | ||
| Q4 25 | $-3.3B | $18.3B | ||
| Q3 25 | $-2.6B | $18.4B | ||
| Q2 25 | $-183.0M | $18.3B | ||
| Q1 25 | $1.4B | $17.9B | ||
| Q4 24 | $3.3B | $17.4B | ||
| Q3 24 | $6.0B | $18.0B | ||
| Q2 24 | $6.8B | $14.5K |
总资产ABBVSW
| Q1 26 | — | $45.2B | ||
| Q4 25 | $134.0B | $45.2B | ||
| Q3 25 | $133.9B | $45.6B | ||
| Q2 25 | $137.2B | $45.7B | ||
| Q1 25 | $136.2B | $44.6B | ||
| Q4 24 | $135.2B | $43.8B | ||
| Q3 24 | $143.4B | $45.0B | ||
| Q2 24 | $141.9B | $26.8K |
负债/权益比ABBVSW
| Q1 26 | — | 0.05× | ||
| Q4 25 | — | 0.73× | ||
| Q3 25 | — | 0.72× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | 45.44× | 0.72× | ||
| Q4 24 | 18.15× | 0.72× | ||
| Q3 24 | 9.70× | 0.73× | ||
| Q2 24 | 8.56× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $204.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 3.24× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ABBVSW
| Q1 26 | — | $204.0M | ||
| Q4 25 | $5.2B | $1.2B | ||
| Q3 25 | $7.0B | $1.1B | ||
| Q2 25 | $5.2B | $829.0M | ||
| Q1 25 | $1.6B | $235.0M | ||
| Q4 24 | $7.0B | $781.0M | ||
| Q3 24 | $5.4B | $320.0M | ||
| Q2 24 | $2.3B | $340.0M |
自由现金流ABBVSW
| Q1 26 | — | — | ||
| Q4 25 | $4.9B | $612.0M | ||
| Q3 25 | $6.6B | $523.0M | ||
| Q2 25 | $4.9B | $307.0M | ||
| Q1 25 | $1.4B | $-242.0M | ||
| Q4 24 | $6.8B | $212.0M | ||
| Q3 24 | $5.2B | $-192.0M | ||
| Q2 24 | $2.0B | $163.0M |
自由现金流率ABBVSW
| Q1 26 | — | — | ||
| Q4 25 | 29.4% | 8.1% | ||
| Q3 25 | 42.1% | 6.5% | ||
| Q2 25 | 31.7% | 3.9% | ||
| Q1 25 | 10.5% | -3.2% | ||
| Q4 24 | 44.7% | 2.8% | ||
| Q3 24 | 35.9% | -2.5% | ||
| Q2 24 | 14.0% | 5.5% |
资本支出强度ABBVSW
| Q1 26 | — | — | ||
| Q4 25 | 2.0% | 7.7% | ||
| Q3 25 | 2.4% | 7.6% | ||
| Q2 25 | 1.7% | 6.6% | ||
| Q1 25 | 1.8% | 6.2% | ||
| Q4 24 | 1.9% | 7.5% | ||
| Q3 24 | 1.7% | 6.7% | ||
| Q2 24 | 1.7% | 6.0% |
现金转化率ABBVSW
| Q1 26 | — | 3.24× | ||
| Q4 25 | 2.87× | 12.32× | ||
| Q3 25 | 37.76× | 4.61× | ||
| Q2 25 | 5.49× | — | ||
| Q1 25 | 1.27× | 0.61× | ||
| Q4 24 | — | 5.35× | ||
| Q3 24 | 3.49× | — | ||
| Q2 24 | 1.66× | 2.58× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
